Thyrocare expands Northern India presence with Polo Labs acquisition

This move will lead to Thyrocare integrating Polo Labs' 14 laboratories spread across Punjab, Haryana, and Himachal Pradesh into its existing network

Medical products, medical equipments
Thyrocare's core operations are centred around its 24/7 centralised processing laboratory in Navi Mumbai. (Photo: Shutterstock)
Anjali Singh Mumbai
2 min read Last Updated : Jul 26 2024 | 12:29 PM IST
Diagnostics company Thyrocare has acquired the pathology business of Polo Labs to strengthen its foothold in Northern India. The PharmEasy-owned diagnostics platform said that the acquisition will boost its reach in Northern India.

This move will lead to Thyrocare integrating Polo Labs' 14 laboratories spread across Punjab, Haryana, and Himachal Pradesh into its existing network.

By combining Polo Labs' network with Thyrocare's infrastructure, the company expects to deliver faster turnaround times, increased convenience for patients, and a wider range of diagnostic services.

Polo Labs' strong regional presence and expertise will be a valuable asset to Thyrocare, allowing them to expand their reach and better serve patients in Northern India. The acquisition aligns with Thyrocare's plan to enhance diagnostic capabilities and offer improved services across the country.

Speaking on this, Rahul Guha, Managing Director and Chief Executive Officer of Thyrocare Technologies, stated, “This strategic acquisition will enhance our diagnostic capabilities and service offerings, leveraging Polo Labs' existing widespread network in North India. We are committed to a seamless integration and look forward to the growth and innovation this acquisition will bring. Together, we will continue to provide exceptional diagnostic services to a broader client base."

“As the company continues to expand its reach and capabilities, it remains dedicated to providing top-notch diagnostic services to communities across India,” Thyrocare stated in its press release.

Thyrocare Technologies is a leading, fully automated diagnostic laboratory chain with a network spanning over 2,000 cities and towns globally. The company is known for delivering high-quality, affordable testing services to both healthcare institutions and individual patients.

Thyrocare's core operations are centred around its 24/7 centralised processing laboratory in Navi Mumbai. This expansive facility, covering over 200,000 square feet, utilises automation to process more than 75,000 samples and conduct over 375,000 tests daily with accuracy.

Polo Labs Private, based out of Punjab, is a pathology diagnostic company with 14 laboratories across Punjab, Haryana, and Himachal Pradesh. Currently, Polo Labs serves a substantial client base and has a significant market presence in Northern India, contributing to the region's healthcare infrastructure.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :ThyrocarePharmEasyPharma sectorPharma industry

First Published: Jul 25 2024 | 7:49 PM IST

Next Story